1. Sladek J.R., Schöler J., Armstrong W.E.: Norepinephrine-vasopressin interactions during aging. In: Sano Y. (Ed.), Structure and function of peptidergic and aminergic neurons. Japan Sci. Soc. Press, Tokyo, 1983, pp. 289–298.
2. Gottfries C.G.: Monoamines and myelin components in aging and dementia disorders. In: Swaab D.F., Fliers E., Mirmiran M., Van Gool W.A., VanHaaren F. (Eds.), Progress in brain research, Vol. 70.Elsevier Sci. Publ., Amsterdam, New York, Oxford, 1986, pp. 133–140.
3. Fliers E., Swaab D.F.: Neuropeptide changes in aging and Alzheimer’s disease. In: Swaab D.F., Fliers E., Mirmiran M., Van Gool W.A., Van Haaren F. (Eds.), Progress in brain research, Vol. 70.Elsevier Sci. Publ., Amsterdam, New York, Oxford, 1986, pp. 141–152.
4. Rusak B., Zucker I.: Neural regulation of circadian rhythms. Physiol. Rev. 59: 449–526, 1979.
5. Ingram D.K., London E.D., Reynolds M.A.: Circadian rhythmicity and sleep: effects of aging in laboratory animals. Neurobiol. Aging 3: 287–297, 1982.